Skip to main content
Displaying 13 - 24 of 45
Display:
12
24
48
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: NASH – the metabolic disease of the liver - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: NASH – the metabolic disease of the liver - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: NASH – the metabolic disease of the liver - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: NASH – the metabolic disease of the liver - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Viral Hepatitis
4
AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020
View
Viral Hepatitis
4
AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020
View
Viral Hepatitis
4
AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy